Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 1999, p. 3925-3927, Vol. 37, No. 12
Departments of
Pathology1 and
Neurology,2 Sree Chitra Tirunal
Institute for Medical Sciences and Technology, Thiruvananthapuram 695 011, Kerala, India
Received 14 May 1999/Returned for modification 24 June
1999/Accepted 2 August 1999
In the present prospective study, a dot immunobinding assay
(Dot-Iba) was standardized to measure the circulating mycobacterial antigen in cerebrospinal fluid (CSF) specimens for the laboratory diagnosis of tuberculous meningitis (TBM). Immunoglobulin G antibody specific for Mycobacterium tuberculosis in a CSF specimen
from a patient with culture-proven TBM was isolated and was coupled with activated cyanogen bromide-Sepharose 4B. By immunosorbent affinity
chromatography, a 14-kDa antigen was isolated from the culture filtrate
of M. tuberculosis. Antibody to the 14-kDa mycobacterial antigen was raised in rabbits. The Dot-Iba in this study gave no
false-positive results with CSF specimens from patients with nontuberculous neurological diseases. The assay gave positive results
for all five patients with culture-proven TBM. The Dot-Iba described in
the present report is simple, rapid, sensitive, specific, and, more
importantly, suitable for routine application in laboratories in
developing countries.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Rapid Diagnosis of Tuberculous Meningitis by a Dot
Immunobinding Assay To Detect Mycobacterial Antigen in Cerebrospinal
Fluid Specimens
*
Corresponding author. Mailing address: Department of
Pathology, Sree Chitra Tirunal Institute for Medical Sciences and
Technology, Thiruvananthapuram-695 011, Kerala, India. Phone:
(91)-471-524508. Fax: (91)-471-446433.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»